Asymmetric mesoporous silica nanoparticles as potent and safe immunoadjuvants provoke high immune responses.

Asymmetric mesoporous silica nanoparticles with a head-tail structure are potent immunoadjuvants for delivering a peptide antigen, generating a higher antibody immune response in mice compared to their symmetric counterparts.

[1]  X. Qu,et al.  A bifunctional nanomodulator for boosting CpG-mediated cancer immunotherapy. , 2017, Nanoscale.

[2]  Chengzhong Yu,et al.  Asymmetric Silica Nanoparticles with Tunable Head-Tail Structures Enhance Hemocompatibility and Maturation of Immune Cells. , 2017, Journal of the American Chemical Society.

[3]  Arturo Ferreira,et al.  Molluskan Hemocyanins Activate the Classical Pathway of the Human Complement System through Natural Antibodies , 2017, Front. Immunol..

[4]  R. Belardi,et al.  Mesoporous silica nanoparticles as a potential vaccine adjuvant against Schistosoma mansoni , 2016 .

[5]  Chun Wang,et al.  Hyaluronic Acid-Modified Cationic Lipid-PLGA Hybrid Nanoparticles as a Nanovaccine Induce Robust Humoral and Cellular Immune Responses. , 2016, ACS applied materials & interfaces.

[6]  Youngjin Choi,et al.  The effect of surface modification of mesoporous silica micro-rod scaffold on immune cell activation and infiltration. , 2016, Biomaterials.

[7]  D. Zhao,et al.  Anisotropic encapsulation-induced synthesis of asymmetric single-hole mesoporous nanocages. , 2015, Journal of the American Chemical Society.

[8]  Youngjin Choi,et al.  Injectable, spontaneously assembling inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy , 2014, Nature Biotechnology.

[9]  M. Skwarczynski,et al.  Self-adjuvanting vaccine against group A streptococcus: application of fibrillized peptide and immunostimulatory lipid as adjuvant. , 2014, Bioorganic & medicinal chemistry.

[10]  D. Irvine,et al.  Antigen Delivery by Lipid-Enveloped PLGA Microparticle Vaccines Mediated by in Situ Vesicle Shedding , 2014, Biomacromolecules.

[11]  D. Zhao,et al.  Biphase stratification approach to three-dimensional dendritic biodegradable mesoporous silica nanospheres. , 2014, Nano letters.

[12]  Meiying Wang,et al.  Engineering an effective immune adjuvant by designed control of shape and crystallinity of aluminum oxyhydroxide nanoparticles. , 2013, ACS nano.

[13]  Rodney C. Ewing,et al.  Dual Surface‐Functionalized Janus Nanocomposites of Polystyrene/Fe3O4@SiO2 for Simultaneous Tumor Cell Targeting and Stimulus‐Induced Drug Release , 2013, Advanced materials.

[14]  Takafumi Ninomiya,et al.  Gold nanoparticles as a vaccine platform: influence of size and shape on immunological responses in vitro and in vivo. , 2013, ACS nano.

[15]  Manisha Pandey,et al.  Long-Term Antibody Memory Induced by Synthetic Peptide Vaccination Is Protective against Streptococcus pyogenes Infection and Is Independent of Memory T Cell Help , 2013, The Journal of Immunology.

[16]  Haitao Jiang,et al.  Enhanced mucosal and systemic immune responses obtained by porous silica nanoparticles used as an oral vaccine adjuvant: effect of silica architecture on immunological properties. , 2012, International journal of pharmaceutics.

[17]  Leaf Huang,et al.  Corrigendum to "Design considerations for liposomal vaccines: Influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens" [Vaccine 30 (13) (2012) 2256-2272] , 2012 .

[18]  J. Magarian Blander,et al.  Beyond pattern recognition: five immune checkpoints for scaling the microbial threat , 2012, Nature Reviews Immunology.

[19]  Yechezkel Barenholz,et al.  Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[20]  S. M. Sivakumar,et al.  Vaccine adjuvants - Current status and prospects on controlled release adjuvancity. , 2011, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

[21]  Q. Huo,et al.  Magnetic-mesoporous Janus nanoparticles. , 2011, Chemical communications.

[22]  Younan Xia,et al.  A facile synthesis of asymmetric hybrid colloidal particles. , 2009, Journal of the American Chemical Society.

[23]  T. Chen,et al.  Controlled assembly of eccentrically encapsulated gold nanoparticles. , 2008, Journal of the American Chemical Society.

[24]  Bali Pulendran,et al.  Translating Innate Immunity into Immunological Memory: Implications for Vaccine Development , 2006, Cell.

[25]  S. Ravaine,et al.  Synthesis of Daisy-Shaped and Multipod-like Silica/Polystyrene Nanocomposites , 2004 .

[26]  Qi Zhou,et al.  Developmental Capacity of Ferret Embryos by Nuclear Transfer Using G0/G1-Phase Fetal Fibroblasts1 , 2003, Biology of reproduction.

[27]  A. Schuchat,et al.  Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. , 2003, The New England journal of medicine.

[28]  V. Schijns,et al.  Vaccine adjuvant technology: from mechanistic concepts to practical applications , 2003, Expert review of vaccines.

[29]  R. Edelman.  The development and use of vaccine adjuvants , 2002, Molecular biotechnology.

[30]  I. Toth,et al.  A Lipid Core Peptide Construct Containing a Conserved Region Determinant of the Group A Streptococcal M Protein Elicits Heterologous Opsonic Antibodies , 2002, Infection and Immunity.

[31]  G. Tolnai,et al.  Preparation and characterization of surface-modified silica-nanoparticles , 2001 .

[32]  P. Ogra,et al.  Vaccination Strategies for Mucosal Immune Responses , 2001, Clinical Microbiology Reviews.

[33]  N. Tornieporth,et al.  A prophylactic hepatitis B vaccine with a novel adjuvant system. , 2001, Vaccine.

[34]  Jules Freund,et al.  Sensitization and Antibody Formation after Injection of Tubercle Bacilli and Paraffin Oil.∗ , 1937 .